Back to Search Start Over

XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7.

Authors :
Liu BQ
Liu RB
Li WP
Mao XT
Li YN
Huang T
Wang HL
Chen HT
Zhong JY
Yang B
Chai RJ
Cao Q
Jin J
Li YY
Source :
EMBO reports [EMBO Rep] 2023 Jan 09; Vol. 24 (1), pp. e55387. Date of Electronic Publication: 2022 Nov 17.
Publication Year :
2023

Abstract

Interferon regulatory factor (IRF) 3 and IRF7 are master regulators of type I interferon (IFN-I)-dependent antiviral innate immunity. Upon viral infection, a positive feedback loop is formed, wherein IRF7 promotes further induction of IFN-I in the later stage. Thus, it is critical to maintain a suitably low level of IRF7 to avoid the hyperproduction of IFN-I. In this study, we find that early expression of IFN-I-dependent STAT1 promotes the expression of XAF1 and that XAF1 is associated specifically with IRF7 and inhibits the activity of XIAP. XAF1-knockout and XIAP-transgenic mice display resistance to viral infection, and this resistance is accompanied by increases in IFN-I production and IRF7 stability. Mechanistically, we find that the XAF1-XIAP axis controls the activity of KLHL22, an adaptor of the BTB-CUL3-RBX1 E3 ligase complex through a ubiquitin-dependent pathway. CUL3-KLHL22 directly targets IRF7 and catalyzes its K48-linked ubiquitination and proteasomal degradation. These findings reveal unexpected functions of the XAF1-XIAP axis and KLHL22 in the regulation of IRF7 stability and highlight an important target for antiviral innate immunity.<br /> (© 2022 The Authors.)

Details

Language :
English
ISSN :
1469-3178
Volume :
24
Issue :
1
Database :
MEDLINE
Journal :
EMBO reports
Publication Type :
Academic Journal
Accession number :
36394357
Full Text :
https://doi.org/10.15252/embr.202255387